About nine months after the FDA fully approved an Alzheimer's drug for the first time, the medicine is trudging through insurance barriers and hesitations from potential patients, the Chicago Tribune reported April 12. 

Pfizer plans to lay off 119 workers at a facility in Everett, Wash., which the drugmaker acquired in its Seagen deal. 

WuXi AppTec, a drugmaker in China that manufactures multiple chemotherapies for U.S. patients, is facing scrutiny from lawmakers concerned about security threats, The New York Times reported April 15. 

In 2024, healthcare pharmacy executives are focused on standardizing their formularies and streamlining drug purchasing, according to 275 hospital pharmacy leaders surveyed by Bluesight. 

Janux Therapeutics, a biopharmaceutical company based in San Diego, is considering selling the business and other options, people with knowledge of the matter told Bloomberg. 

The number of ongoing drug shortages in the U.S. is at its highest since 2001 — when the American Society of Health-System Pharmacists began tracking data. There are now 323 medications in low supply. 

The U.S. might soon see an approved respiratory syncytial virus vaccine for adults younger than 60. 

Biosimilars can now be substituted as part of regular formulary maintenance changes, according to CMS' Medicare Advantage and Part D Final Rule for 2025. However, the change could significantly increase patient cost sharing, according to an article on the American…

Three pharmacy benefit managers accounted for nearly 80% of all prescription claims handled in 2023, according to an April 9 report from the Drug Channels Institute.

A jury awarded $42.4 million to the estate of a patient who died after staff failed to get the patient's baclofen prescription filled in a timely manner, a case study posted on the American Pharmacy Association website said.